Results 161 to 170 of about 373,386 (221)

Blazing Trails With Research: Paving the Way for Advanced Practice Providers. [PDF]

J Adv Pract Oncol
Callaway C, Hogan K, Jennrich V, Poore A.   +3 more
europepmc   +1 more source

Current Assessment of Existing Biospecimen Use in Population-Based Cancer Research. [PDF]

Biopreserv Biobank
Hanisch R, Gallicchio L, Daee D, Mahabir S, Nelson S, Carrick DM.   +5 more
europepmc   +1 more source

The Centers for Medicare and Medicaid Services and others misunderstand stool testing for colorectal cancer. [PDF]

J Natl Cancer Inst
Coronado GD, Hoffman RM, Llavona-Ortiz J, Rutter CM.   +3 more
europepmc   +1 more source

Reach, Acceptability, and Effectiveness of Proactive Outreach and Varenicline with Cancer-Focused Counseling for Patients with Cancer: A Pilot Randomized Comparative Effectiveness Trial. [PDF]

JCO Oncol Adv
Kaye JT, Piasecki TM, Fiore MC, Baker TB, Zehner ME, Williams BS, Slutske WS, McCarthy DE.   +7 more
europepmc   +1 more source

An innovative treatment for lung cancer using gene-engineered human-induced pluripotent stem cell-derived natural killer cells. [PDF]

Cancer Immunol Immunother
Sato Y, Goto K, Yagishita S, Miyata K, Uesugi N, Torisawa YS, Naritomi Y, Takahashi R, Sho R, Takeno Y, Kurachi K, Yamada M, Higashi Y, Kimura H, Hamada A, Nishigaki F, Tamura K.   +16 more
europepmc   +1 more source

The Role of Physical Activity in Breast Cancer Prevention [PDF]

, 2019
Edwards, Darryl
core  

C. Norman Coleman's Legacy in Radiation Research and Global Health: A Cancer Research and Care Perspective. [PDF]

Disaster Med Public Health Prep
Aryankalayil MJ, Prasanna PGS, Buchsbaum JC.   +2 more
europepmc   +1 more source

Breaking the vape-stress cycle: communicating mental health risks of vaping to mitigate reactance. [PDF]

J Public Health (Oxf)
Kim HM, Lee DN, Stevens HR, Stevens EM.
europepmc   +1 more source

Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. [PDF]

J Natl Cancer Inst
Zhang T, Hua X, Mohindroo C, Wang X, Dutta D, Liu J, Katta S, Li SA, Wang J, Antwi SO, Arslan AA, Beane Freeman LE, Bracci PM, Canzian F, Du M, Gallinger S, Goodman PJ, Katzke V, Kooperberg C, Le Marchand L, Neale RE, Patel AV, Perdomo S, Shu XO, Visvanathan K, Van Den Eeden SK, White E, Zheng W, Albanes D, Andreotti G, Bamlet WR, Brennan P, Buring JE, Chanock SJ, Chen Y, Darst B, Ferrari P, Giovannucci EL, Goggins M, Haiman C, Hassan M, Holly EA, Hung RJ, Jones MR, Kraft P, Kurtz RC, Malats N, Moore SC, Ng K, Oberg AL, Orlow I, Peters U, Porta M, Rabe KG, Rothman N, Sánchez MJ, Sesso HD, Silverman DT, Southey MC, Um CY, Yarmolinsky J, Yu H, Yuan C, Zhong J, Wolpin BM, Risch HA, Amundadottir LT, Klein AP, Yu K, Zhang H, Stolzenberg-Solomon RZ.   +70 more
europepmc   +1 more source

Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i>^<i>V600E</i> Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H. [PDF]

JCO Precis Oncol
Salama AKS, Wang V, Macrae ER, Park JI, Chen HX, Gray RJ, McShane LM, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Armstrong DK, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT.   +18 more
europepmc   +1 more source